Search
forResearch 10 of 297
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Nilotinib-Induced Keratosis Pilaris
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- The PDGF/PDGFR pathway as a drug target
- Dasatinib-Induced Leukotrichia in a Patient With Chronic Myelogenous Leukemia
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →